首页> Frontiers in pharmacology> RU486 Metabolite Inhibits CCN1/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion.

RU486 Metabolite Inhibits CCN1/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion.

导出 LinkOut

翻译打印收藏纠错

第一作者： Suhong,Yu

第一单位： Cancer Metastasis Alert and Prevention Center, and Biopharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Fuzhou University, Fuzhou, China.

作者： Suhong,Yu ^[1] ; Cuicui,Yan ^[1] ; Wenjing,Wu ^[1] ; Sudan,He ^[1] ; Min,Liu ^[1] ; Jian,Liu ^[1] ; Xingtian,Yang ^[1] ; Ji,Ma ^[1] ; Yusheng,Lu ^[2] ; Lee,Jia ^[3]

作者单位： Cancer Metastasis Alert and Prevention Center, and Biopharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Fuzhou University, Fuzhou, China. ^[1] Institute of Oceanography, Minjiang University, Fuzhou, China. ^[2] Cancer Metastasis Alert and Prevention Center, and Biopharmaceutical Photocatalysis of State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Fuzhou University, Fuzhou, China.;Institute of Oceanography, Minjiang University, Fuzhou, China. ^[3]

关键词 CYR61 MDA-MB-231/HPMEC co-culture integrin αvβ1 metapristone metastasis chemoprevention

DOI 10.3389/fphar.2019.01296

PMID 31824306

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交